Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells
Open Access
- 1 January 1994
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 95 (1) , 148-155
- https://doi.org/10.1111/j.1365-2249.1994.tb06029.x
Abstract
It has previously been shown that murine sarcoma cells express high-affinity IL-4 receptors (1L-4R) which are internalized after binding to the ligand (Puri et al., Cancer Res 1991; 51:3011-7). We have also reported that human renal cell carcinoma cells express high-affinity IL-4R. and IL-4 inhibits tumour growth in vitro (Obiri et al, J Clin Invest 1993; 91:88). In this study we investigated the expression and function of IL-4R on other human solid tumours. Human melanoma, ovarian carcinoma and breast carcinoma cell lines were assessed for the cell surface expression of IL-4R by radio-ligand receptor binding and for IL-4R gene expression by Northern blot analysis. Primary cultures of mesothelioma and neurofibrosarcoma cells were similarly investigated. Human melanoma, ovarian carcinoma and breast carcinoma cell lines expressed IL-4R on their cell surface with a dissociation constant (Kd) of 140-549 pM. These tumour lines expressed a single 4 kb species of mRNA for IL-4R. Similarly, primary cultures of mesothelioma and neurofibrosarcoma cells were positive for the IL-4R mRNA by Northern blot analysis. Fresh, non-cultured mesothelioma and neurofibrosarcoma tumour sections were also positive for the presence of IL-4R as determined by immunohistochemistry of frozen sections using anti-IL-4R antibody. In order to study possible functions of IL-4R, we evaluated the effects of 11.-4 on cell growth and its effect on MHC antigen expression in the presence or absence of interferon-gamma (IFN-γ)- In tissue culture, IL-4 reduced the growth of tumour cell lines and primary cell cultures studied. IL-4 had very title effect on MHC class I antigen expression on ovarian, breast and melanoma cell lines; however. MHC class I (HLA-DR) expression was enhanced on melanoma and breast carcinoma cells. IL-4 also enhanced the IFN-γ-induced class II expression on melanoma and breast carcinoma cells. Taken together, our observations indicate that IL-4R are expressed on a variety of human solid tumours and these receptors may be functional. IL-4 alone and in combination with IFN-γ may play a role in host immune response against cancers.Keywords
This publication has 27 references indexed in Scilit:
- Interleukin-4 is a potent mitogen for capillary endotheliumBiochemical and Biophysical Research Communications, 1991
- Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?British Journal of Cancer, 1989
- Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophoresNature, 1989
- Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.The Journal of Experimental Medicine, 1987
- Molecular structure of human lymphocyte receptor for immunoglobulin ECell, 1986
- T-cell and mast cell lines respond to B-cell stimulatory factor 1.Proceedings of the National Academy of Sciences, 1986
- Identification of a T Helper Cell-Derived Lymphokine That Activates Resting T LymphocytesScience, 1986
- Secretion of IgG1 induction factor by T cell clones and hybridomasEuropean Journal of Immunology, 1985
- Interleukin-induced increase in Ia expression by normal mouse B cells.The Journal of Experimental Medicine, 1984
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982